Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
25.00
+0.26 (1.05%)
At close: May 29, 2026, 4:00 PM EDT
24.85
-0.15 (-0.60%)
After-hours: May 29, 2026, 6:34 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Research and Development of the Company’s NPS Technology | 350.00K | - | - | 700.00K | 1.42M | | | | | |
Research and Development of the Company’s NPS Technology Growth | - | - | - | -50.63% | - | | | | | |
| 350.00K | - | - | 700.00K | 1.42M | | | | | |
| - | - | - | -50.63% | - | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 517.00K | 1.18M | | | | | |
| -56.26% | - | | | | | |
| 183.00K | 236.00K | | | | | |
| -22.46% | - | | | | | |
| 700.00K | 1.42M | | | | | |
| -50.63% | - | | | | | |
Source: S&P Global Market Intelligence.
